Abstract
The COVID-19 pandemic brought about major changes in cancer clinical trials. In its aftermath, the community has an opportunity to incorporate some of these changes as part of the future of trial conduct to make it more patient centered.
Cite
CITATION STYLE
APA
Flaherty, K. T., Doroshow, J. H., Galbraith, S., Ribas, A., Kluetz, P. G., Pazdur, R., & Theoret, M. R. (2021). Rethinking cancer clinical trial conduct induced by covid-19: An academic center, industry, government, and regulatory agency perspective. Cancer Discovery, 11(8), 1881–1885. https://doi.org/10.1158/2159-8290.CD-21-0850
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free